Consumers with the imported pans should throw them away due to the severe health risks posed by lead, the agency warns.
Novo Nordisk is using its ticket for an extra-speedy regulatory review granted through the FDA’s Commissioner’s National ...
Analysts at Guggenheim Partners expect Voyxact to see “broad commercial uptake” given its relatively broad label compared ...
The U.S. Food and Drug Administration has proposed to withdraw a rule that would have ensured certain cosmetics were tested ...
The Trump administration is withdrawing a proposal to require cosmetic companies to test their talc-containing products for ...
MedPage Today on MSN
Makary, RFK Jr. in Power Struggle; IHS Doctors Allege Censorship; Unusual FDA Vote
FDA chief Mary Makary, MD, MPH, and his boss HHS Secretary Robert F. Kennedy Jr. are locked in a power struggle over vaccine ...
Powerful” new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and ...
The Environmental Working Group is criticizing the Food and Drug Administration (FDA) after the agency abruptly withdrew a proposed rule meant to prevent asbestos contamination in talc-based ...
It’s getting out of control. It’s distorting the doctor-patient relationship, these endless pharmaceutical ads,” Makary told ...
The FDA has delayed a decision on Ascendis Pharma’s dwarfism drug candidate TransCon CNP, pushing back the deadline by three ...
Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...
Zantac and other ranitidine products were withdrawn nationwide in April 2020 over concerns an impurity could cause cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback